Reading Time: 3 mins
Last Modified: October 22, 2020
Michael McGrady - author
Michael McGrady is a critically acclaimed journalist based in the U.S. state of Colorado. He has an extensive background covering harm reduction and risk minimization topics within the realm of public health. Much of his work focuses on drug legalization and the modernization of recreational drug laws. You can find McGrady’s writing in outlets like Filter Magazine, Inside Sources, The South China Morning Post, and several others across the globe.
More to Read
April 22, 2024
Miami Judge Declares Mistrial in Ovarian Cancer Case filed against J&J talc
>READ
April 8, 2024
Florida Jury Hears Opening Statements Against Johnson & Johnson
>READ
March 18, 2024
Historic Victory: EPA Seals the Fate of Asbestos in America
>READ
February 26, 2024
Healing Heroes: Expanding VA Support for Asbestos-Exposed Veterans
>READ
February 1, 2024
Talc Producer Proposes $862.5M Trust to Settle Cancer Claims
>READ
January 24, 2024
The Cost of Powder: J&J’s $700 Million Leap to Settle Asbestos Cancer Claims
>READ
To contribute to our constant feed of relevant legal matters
News & Data
FILTER:
Melissa Bill
4 mins read - May 7, 2024
Johnson & Johnson is on the verge of settling more than 50,000 lawsuits alleging that the use of its widely-used talc baby powder led to claimants developing ovarian cancer....
Melissa Bill
3 mins read - May 3, 2024
On Friday, an Illinois court ordered Johnson & Johnson and Kenvue to pay $45 million in a case that involved a family that alleged a link between the relative’s death after...
Mary Pieper
3 mins read - May 2, 2024
In the ongoing battle against mesothelioma, the introduction of ADI-PEG20 (pegargiminase) marks a significant milestone. This innovative drug, hailed for its novel approach,...
© 2024 Mesowatch. All right reserved.